MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0085457
Anicare Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹13.97 Cr
▼ 31% YoY
Net profit · FY 2025
₹36.27 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹1.15 Cr
EBITDA margin 8.3%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹8.26 Cr
Secured borrowings
Company age
32 yrs
Est. 1994
Employees · EPFO
26
Provident fund records
About Anicare Pharmaceuticals Private Limited
Data last updated:
Anicare Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 September 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1994PTC081420. Its GSTIN is 27AAACA8565F1ZM (Maharashtra).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Manisha Anantrai Mehta (Whole-Time Director) and Amit Anantrai Mehta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1001 Cts No. 5877 Vimalnath M P Vaidya Marg Ghatkopar (E) Kirol Village, Mumbai, Maharashtra, India – 400077.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.97 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net profit of ₹36.27 Lakh (net margin 2.6%) and EBITDA of ₹1.15 Cr (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 9% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Anicare Pharmaceuticals. As per MCA filings, the company has open charges of ₹8.26 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Anicare Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0085457). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anicarepharma.com.
Company details
CIN U51397MH1994PTC081420
Registration Number 081420
Incorporation Date 23 September 1994
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0085457
Key People
Manisha Anantrai Mehta Whole-Time Director Amit Anantrai Mehta Whole-Time Director Hitesh Anantrai Mehta Director Recognitions & Rankings of Anicare Pharmaceuticals
Contact details
Anicare Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is anicarepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1001 Cts No. 5877 Vimalnath M P Vaidya Marg Ghatkopar (E) Kirol Village, Mumbai, Maharashtra, India – 400077
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anicare Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anicare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Anicare Pharmaceuticals operates one associated brand: Anicare Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Anicare Pharmaceuticals is engaged in manufacturing topical pharmaceuticals and cosmetics. | anicarepharma.com |
Business activity
The main business activity of Anicare Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anicare Pharmaceuticals Private Limited, buy the company report.
Financials of Anicare Pharmaceuticals Private Limited
FY 2025 filings availableAnicare Pharmaceuticals Private Limited reported revenue of ₹13.97 Cr (down 31% YoY) for FY 2025.
Revenue · FY 2025
₹13.97 Cr ▼ 31%
Net profit · FY 2025
₹36.27 Lakh margin 2.6%
EBITDA · FY 2025
₹1.15 Cr margin 8.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 14%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 16%
5 years · compounded
▼ 11%
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 31% fall in the latest year. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.15 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹36.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anicare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anicare Pharmaceuticals Private Limited
Anicare Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Anantrai Mehta | Whole-Time Director | 23 Sep 1994 | 32 Years 1 Months | Current |
| Amit Anantrai Mehta | Whole-Time Director | 23 Sep 1994 | 32 Years 1 Months | Current |
| Hitesh Anantrai Mehta | Director | 23 Sep 1994 | 32 Years 1 Months | Current |
Peer comparison
Anicare Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lilium International Private Limited | ₹14 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Unjha Formulations Limited | ₹13.98 Cr (FY 2025) | -24.0% | Khali, Gujarat, India | |||
| Anicare Pharmaceuticals Private Limitedthis company | ₹13.97 Cr (FY 2025) | ₹36.27 Lakh | 2.6% | -31.0% | 26 | Mumbai, Maharashtra, India |
| Bentley and Remington Private Limited | ₹13.96 Cr (FY 2025) | 6.0% | Bangalore, Karnataka, India | |||
| Stereokem Private Limited | ₹13.93 Cr (FY 2024) | 29.0% | Hyderabad, Telangana, India | |||
| Santis Pharmaceuticals Private Limited | ₹13.9 Cr (FY 2021) | 14.0% | Ahmedabad, Gujarat, India | |||
| DJ Pharmaceuticals Private Limited | ₹13.89 Cr (FY 2020) | 14.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Anicare Pharmaceuticals Private Limited, buy the company report.
Auditor
Anicare Pharmaceuticals Private Limited is audited by Chetan Doshi and Company for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chetan Doshi and Company | FY 2022 | 101777W |
Shareholding
The shareholding of Anicare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Anicare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jun 2013 | 10439682 | Bank of India | ₹37 Lakh | Open | |
| 20 Sep 2010 | 10248717 | Bank of India | ₹40 Lakh | Open | |
| 22 Aug 2008 | 10120232 | Bank of India | ₹2.54 Cr | Open | |
| 09 Feb 2008 | 10125397 | Bank of India | ₹3.75 Cr | Open | |
| 26 Aug 2005 | 80014987 | Bank of India | ₹85.75 Lakh | Open |
To see the full charge records of Anicare Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Anicare Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (S) | Filed against the company by an individual | Disposed |
To see the full case history of Anicare Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anicare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Anicare Pharmaceuticals Private Limited has a workforce of 26 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
26
Active EPFO establishments
1
GST
Anicare Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA8565F1ZM | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Anicare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anicare Pharmaceuticals Private Limited has 3 board changes on record since 1994: 3 appointments. The latest: Amit Anantrai Mehta was appointed as Whole-Time Director on 23 Sep 1994.
AGM
Anicare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Anicare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Bank Of India of Rs. 375.00 Lakh registered on 09 Feb 2008 with Charge ID 10125397 was modified on 29 Apr 2022.
Charges
A charge with Bank Of India of Rs. 254.00 Lakh registered on 22 Aug 2008 with Charge ID 10120232 was modified on 23 Nov 2013.
Charges
A charge with Bank Of India amounted to Rs. 37.00 Lakh with Charge ID 10439682 was registered on 20 Jun 2013.
Charges
A charge with Bank Of India amounted to Rs. 40.00 Lakh with Charge ID 10248717 was registered on 20 Sep 2010.
Charges
A charge with Bank Of India amounted to Rs. 254.00 Lakh with Charge ID 10120232 was registered on 22 Aug 2008.
Charges
A charge with Bank Of India amounted to Rs. 375.00 Lakh with Charge ID 10125397 was registered on 09 Feb 2008.
Charges
A charge with Bank Of India of Rs. 85.75 Lakh registered on 26 Aug 2005 with Charge ID 80014987 was modified on 02 Dec 2006.
Charges
A charge with Bank Of India amounted to Rs. 85.75 Lakh with Charge ID 80014987 was registered on 26 Aug 2005.
Charges
A charge with Bank Of India of Rs. 10.50 Lakh registered on 10 Dec 1999 with Charge ID 90157360 was modified on 11 May 2000.
Charges
A charge with Bank Of India of Rs. 8.00 Lakh registered on 18 Sep 1997 with Charge ID 90156665 was modified on 11 May 2000.
10 earlier events are in the company report.
Frequently asked questions
Anicare Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 September 1994 (32+ years old) and is registered under CIN U51397MH1994PTC081420.
Anicare Pharmaceuticals has 3 current directors:
- Manisha Anantrai Mehta - Whole-Time Director
- Amit Anantrai Mehta - Whole-Time Director
- Hitesh Anantrai Mehta - Director
The latest financial statements of Anicare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anicare Pharmaceuticals is 27AAACA8565F1ZM, registered in Maharashtra.
The CIN (Corporate Identification Number) of Anicare Pharmaceuticals is U51397MH1994PTC081420. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anicare Pharmaceuticals has 1 court case on record: 1 filed against it.
Anicare Pharmaceuticals was incorporated on 23 September 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Anicare Pharmaceuticals by revenue are Lilium International Private Limited, Unjha Formulations Limited, Bentley and Remington Private Limited, Stereokem Private Limited, Santis Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Anantrai Mehta was appointed as Whole-Time Director on 23 Sep 1994. Hitesh Anantrai Mehta was appointed as Director on 23 Sep 1994. Manisha Anantrai Mehta was appointed as Whole-Time Director on 23 Sep 1994.
Yes, Anicare Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0085457).
Anicare Pharmaceuticals can be reached through the website anicarepharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages